Paris Saponins enhance radiosensitivity in a gefitinib‑resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest

Zhao,Peng‑Jun; Song,Shui‑Chuan; Du,Lei‑Wen; Zhou,Guo‑Hua; Ma,Sheng‑Lin; Li,Jin‑Hui; Feng,Jian‑Guo; Zhu,Xin‑Hai; Jiang,Hao

doi:10.3892/mmr.2016.4865

Paris Saponins enhance radiosensitivity in a gefitinib‑resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest

Authors:
- Peng‑Jun Zhao
- Shui‑Chuan Song
- Lei‑Wen Du
- Guo‑Hua Zhou
- Sheng‑Lin Ma
- Jin‑Hui Li
- Jian‑Guo Feng
- Xin‑Hai Zhu
- Hao Jiang
View Affiliations

Affiliations: Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, P.R. China, Department of Gastroenterology, 117 Hospital of People's Liberation Army, Hangzhou, Zhejiang 310013, P.R. China, Department of Oncology, Anji People's Hospital, Anji, Zhejiang 313399, P.R. China, Department of Oncology, Hangzhou First People's Hospital, Hangzhou, Zhejiang 310006, P.R. China, Department of Chinese Medicine and Rehabilitation, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China, Department of Thoracic Surgery, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China, Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China
Published online on: February 4, 2016 https://doi.org/10.3892/mmr.2016.4865
Pages: 2878-2884

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acquired resistance to epidermal growth factor inhibitors has been reported to be associated with cross‑resistance to radiation. Paris Saponins (PSs) exert a wide range of pharmacological activities, including cell apoptosis induction, multidrug resistance inhibition, angiogenesis inhibition and tumor cell migration by modulating various signaling pathways. The present study aimed to investigate the radiosensitization effects of PSII, PSVI and PSVII in a gefitinib‑resistant PC‑9‑ZD lung adenocarcinoma cell line, and the possible mechanism underlying their function. A clonogenic assay was performed to determine the effects of PS radiosensitization on the PC‑9‑ZD cell line. The cell cycle was analyzed by flow cytometry, and cell apoptosis was analyzed with Annexin V/propidium iodide and Hoechst staining. Protein expression levels were detected by western blotting. The results of the present study revealed a significant increase in PC‑9‑ZD cell line radiosensitivity following treatment with PSs. PSs induced G2/M cell cycle phase arrest and apoptosis of the irradiated PC‑9‑ZD cells. Notably, the expression levels of B cell lymphoma 2 (Bcl‑2) were downregulated, and those of caspase‑3, Bcl‑2‑associated X protein (Bax) and p21/Waf1/Cip1 were upregulated following treatment with PSs. The present results demonstrated that PSs induced radiosensitivity in gefitinib‑resistant cells by inducing G2/M phase arrest and by enhancing the apoptotic response via the modulation of caspase‑3, Bax, Bcl‑2 and p21/Waf1/Cip1 expression.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Sordella R, Bell DW, Haber DA and Settleman J: Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science. 305:1163–1167. 2004. View Article : Google Scholar : PubMed/NCBI
3	Workman P: Altered states: Selectively drugging the Hsp90 cancer chaperone. Trends Mol Med. 10:47–51. 2004. View Article : Google Scholar : PubMed/NCBI
4	Kobayashi N, Toyooka S, Soh J, Yamamoto H, Dote H, Kawasaki K, Otani H, Kubo T, Jida M, Ueno T, et al: The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung cancer. 75:161–166. 2012. View Article : Google Scholar
5	Langer CJ: Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: Is afatinib better or simply newer? J Clin Oncol. 31:3303–3306. 2013. View Article : Google Scholar : PubMed/NCBI
6	Arcila ME, Nafa K, Chaft JE, Rekhtman N, Lau C, Reva BA, Zakowski MF, Kris MG and Ladanyi M: EGFR exon 20 insertion mutations in lung adenocarcinomas: Prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther. 12:220–229. 2013. View Article : Google Scholar : PubMed/NCBI
7	Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG and Varmus H: Acquired resistance of lung adeno-carcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2:e732005. View Article : Google Scholar
8	Gainor JF and Shaw AT: Emerging paradigms in the development of resistance to tyrosine kinase inhibitors in lung cancer. J Clin Oncol. 31:3987–3996. 2013. View Article : Google Scholar : PubMed/NCBI
9	Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M and Riely GJ: Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res. 19:2240–2247. 2013. View Article : Google Scholar : PubMed/NCBI
10	Lutz ST, Jones J and Chow E: Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 32:2913–2919. 2014. View Article : Google Scholar : PubMed/NCBI
11	Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, et al: Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIA/B nonsmall cell lung carcinoma: A modified phase I/II trial. Cancer. 92:1213–1223. 2001. View Article : Google Scholar : PubMed/NCBI
12	Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ and Whittle J: Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. J Clin Oncol. 33:567–574. 2015. View Article : Google Scholar :
13	Jiang H, Zhao P, Feng J, Su D and Ma S: Effect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line. Oncol Lett. 7:2059–2064. 2014.PubMed/NCBI
14	Yan L, Gao W, Zhang Y and Wang Y: A new phenylpropanoid glycosides from Paris polyphylla var. yunnanensis. Fitoterapia. 79:306–307. 2008. View Article : Google Scholar : PubMed/NCBI
15	Negi JS, Bisht VK, Bhandari AK, Bhatt VP, Singh P and Singh N: Paris polyphylla: Chemical and biological prospectives. Anticancer Agents Med Chem. 14:833–839. 2014. View Article : Google Scholar : PubMed/NCBI
16	He H, Zheng L, Sun YP, Zhang GW and Yue ZG: Steroidal saponins from Paris polyphylla suppress adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev. 15:10911–10916. 2014. View Article : Google Scholar
17	Cheng ZX, Liu BR, Qian XP, Ding YT, Hu WJ, Sun J and Yu LX: Proteomic analysis of anti-tumor effects by Rhizoma Paridis total saponin treatment in HepG2 cells. J Ethnopharmacol. 120:129–137. 2008. View Article : Google Scholar : PubMed/NCBI
18	Man S, Gao W, Zhang Y, Yan L, Ma C, Liu C and Huang L: Anti-tumor and antimetastatic activities of Rhizoma Paridis saponins. Steroids. 74:1051–1056. 2009. View Article : Google Scholar : PubMed/NCBI
19	Ma DD, Lu HX, Xu LS and Xiao W: Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions. J Int Med Res. 37:631–640. 2009. View Article : Google Scholar : PubMed/NCBI
20	Shuli M, Wenyuan G, Yanjun Z, Chaoyi M, Liu Y and Yiwen L: Paridis saponins inhibiting carcinoma growth and metastasis in vitro and in vivo. Arch Pharm Res. 34:43–50. 2011. View Article : Google Scholar : PubMed/NCBI
21	GuangLie C, WeiShi G, GaiLing H and JianPing C: Effect of Paris saponin on antitumor and immune function in U14 tumor-bearing mice. Afr J Tradit Complement Altern Med. 10:503–507. 2013.PubMed/NCBI
22	Wen F, Yin H, Chen C, Liu X, Xue D, Chen T, He J and Zhang H: Chemical characteristics of saponins from Paris fargesii var. brevipetala and cytotoxic activity of its main ingredient, Paris saponin H. Fitoterapia. 83:627–635. 2012. View Article : Google Scholar : PubMed/NCBI
23	Zhao Y, Kang LP, Liu YX, Liang YG, Tan DW, Yu ZY, Cong YW and Ma BP: Steroidal saponins from the rhizome of Paris poly- phylla and their cytotoxic activities. Planta Med. 75:356–363. 2009. View Article : Google Scholar
24	Yan LL, Zhang YJ, Gao WY, Man SL and Wang Y: In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis. Exp Oncol. 31:27–32. 2009.PubMed/NCBI
25	He H, Sun YP, Zheng L and Yue ZG: Steroidal saponins from Paris polyphylla induce apoptotic cell death and autophagy in A549 human lung cancer cells. Asian Pac J Cancer Prev. 16:1169–1173. 2015. View Article : Google Scholar : PubMed/NCBI
26	Jiang H, Zhao PJ, Su D, Feng J and Ma SL: Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep. 9:2265–2272. 2014.PubMed/NCBI
27	Xiao X, Bai P, Bui Nguyen TM, Xiao J, Liu S, Yang G, Hu L, Chen X, Zhang X, Liu J and Wang H: The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway. Mol Cancer Ther. 8:1179–1188. 2009. View Article : Google Scholar : PubMed/NCBI
28	Xiao M, Dai X, He X, Zhou R, Zhang B, Hu G, Huang Z and Fan X: Paris saponin I induces G₂/M cell cycle arrest and apoptosis in human gastric carcinoma SGC7901 cells. J Huazhong Univ Sci Technolog Med Sci. 31:768–772. 2011. View Article : Google Scholar : PubMed/NCBI
29	Zhao P, Jiang H, Su D, Feng J, Ma S and Zhu X: Inhibition of cell proliferation by mild hyperthermia at 43°C with Paris Saponin I in the lung adenocarcinoma cell line PC-9. Mol Med Rep. 11:327–332. 2015.
30	Xiao X, Yang M, Xiao J, Zou J, Huang Q, Yang K, Zhang B, Yang F, Liu S, Wang H and Bai P: Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration. Cancer Chemother Pharmacol. 73:807–818. 2014. View Article : Google Scholar : PubMed/NCBI
31	Xiao X, Zou J, Bui-Nguyen TM, Bai P, Gao L, Liu J, Liu S, Xiao J, Chen X, Zhang X and Wang H: Paris saponin II of Rhizoma Paridis - a novel inducer of apoptosis in human ovarian cancer cells. Biosci Trends. 6:201–211. 2012. View Article : Google Scholar : PubMed/NCBI
32	Li Y, Sun Y, Fan L, Zhang F, Meng J, Han J, Guo X, Zhang D, Zhang R, Yue Z and Mei Q: Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway. Biochem Pharmacol. 88:150–157. 2014. View Article : Google Scholar : PubMed/NCBI
33	Zhang W, Zhang D, Ma X, Liu Z, Li F and Wu D: Paris saponin VII suppressed the growth of human cervical cancer Hela cells. Eur J Med Res. 19:412014. View Article : Google Scholar : PubMed/NCBI
34	Fan L, Li Y, Sun Y, Yue Z, Meng J, Zhang X, Zhang R, Zhang D, Zhang F and Mei Q: Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells. Mol Med Rep. 11:705–711. 2015.
35	Li Y, Fan L, Sun Y, Miao X, Zhang F, Meng J, Han J, Zhang D, Zhang R, Yue Z and Mei Q: Paris saponin VII from trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition and apoptosis augmentation. J Ethnopharmacol. 154:728–734. 2014. View Article : Google Scholar : PubMed/NCBI
36	Ji Y, Ma SL, Zhang YP, Tang JJ, Wu YM and Lu YJ: Combined treatment with TNF-α/gefitinib alleviates the resistance to gefitinib in PC-9 cells. Anticancer Drugs. 20:832–837. 2009. View Article : Google Scholar : PubMed/NCBI
37	Deckbar D, Jeggo PA and Löbrich M: Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol. 46:271–283. 2011. View Article : Google Scholar : PubMed/NCBI
38	McIlwain DR, Berger T and Mak TW: Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
39	Hu Q, Peng J, Liu W, He X, Cui L, Chen X, Yang M, Liu H, Liu S and Wang H: Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int J Clin Exp Pathol. 7:5057–5070. 2014.PubMed/NCBI
40	Dhar R, Persaud SD, Mireles JR and Basu A: Proteolytic cleavage of p70 ribosomal S6 kinase by caspase-3 during DNA damage-induced apoptosis. Biochemistry. 48:1474–1480. 2009. View Article : Google Scholar : PubMed/NCBI
41	Shroff EH, Snyder C and Chandel NS: Bcl-2 family members regulate anoxia-induced cell death. Antioxid Redox Signal. 9:1405–1409. 2007. View Article : Google Scholar : PubMed/NCBI
42	Engelman JA and Jänne PA: Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell Lung cancer. Clin Cancer Res. 14:2895–2899. 2008. View Article : Google Scholar : PubMed/NCBI
43	Huang S, Benavente S, Armstrong EA, Li C, Wheeler DL and Harari PM: p53 modulates acquired resistance to EGFR inhibitors and radiation. Cancer Res. 71:7071–7079. 2011. View Article : Google Scholar : PubMed/NCBI
44	Begg AC, Stewart FA and Vens C: Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 11:239–253. 2011. View Article : Google Scholar : PubMed/NCBI
45	Chetty C, Bhoopathi P, Rao JS and Lakka SS: Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer. 124:2468–2477. 2009. View Article : Google Scholar : PubMed/NCBI